Drug intelligence / Profile preview

albendazole

Development stage
Approved
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

Albendazole is a broad-spectrum benzimidazole anthelmintic used to treat a variety of parasitic worm infections, including neurocysticercosis (caused by the pork tapeworm) and cystic hydatid disease (caused by the dog tapeworm)[1][2][3][4]. It is also used for other helminth infections and has activity against some protozoa[5]. Albendazole works by binding to the colchicine-sensitive site of beta-tubulin in susceptible parasites, inhibiting microtubule polymerization. This disrupts glucose uptake and depletes glycogen stores, leading to energy depletion, immobilization, and death of the parasite[3][5][6]. The drug may also impair cell division in parasites by preventing spindle fiber formation[5].

Brand names
Albenza
Other names
albendazole
02

Targets

TUBB (Tubulin (alpha and beta subunits))

Beyond the preview

Go deeper on albendazole.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on albendazole.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call